The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
In vivo protection against endotoxin by plasma high density lipoprotein.
Open accessAbstract
Overwhelming bacterial infection is accompanied by fever, hypotension, disseminated intravascular coagulation, and multiple organ failure leading to death in 30-80% of cases. These classical symptoms of septic shock are caused by potent cytokines that are produced in response to endotoxin released from Gram-negative bacteria. Treatments with antibodies and receptor antagonists to block endotoxin or cytokine mediators have given mixed results in clinical trials. High density lipoprotein (HDL) is a natural component of plasma that is known to neutralize endotoxin in vitro. We report here that raising the plasma HDL concentration protects mice against endotoxin in vivo. Transgenic mice with 2-fold-elevated plasma HDL levels had more endotoxin bound to HDL, lower plasma cytokine levels, and improved survival rates compared with low-HDL mice. Intravenous infusion of HDL also protected mice, but only when given as reconstituted HDL prepared from phospholipid and either HDL apoprotein or an 18-amino acid peptide synthesized to mimic the structure of apolipoprotein A-I of HDL. Intact plasma HDL was mildly toxic, and HDL apoprotein was ineffective. The effectiveness of the reconstituted peptide renders very unlikely any significant contribution to protection by trace proteins in apo-HDL. These data suggest a simple leaflet insertion model for binding and neutralization of lipopolysaccharide by phospholipid on the surface of HDL. Plasma HDL may normally act to protect against endotoxin; this protection may be augmented by administration of reconstituted HDL or reconstituted peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
Pugin, J., Schürer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., & Tobias, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2744 · Cited by 831
Mathison, J. C., Wolfson, E., & Ulevitch, R. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113540 · Cited by 591
Raetz, C. R. H., Ulevitch, R. I., Wright, S. D., Sibley, C. H., Ding, A., & Nathan, C. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.12.1916089 · Cited by 507
[6] Sequential flotation ultracentrifugation
Schumaker, V. N., & Puppione, D. L. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28066-0 · Cited by 493
Matz, C. E., & Jonas, A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34756-2 · Cited by 440
Mathison, J. C., & Ulevitch, R. J. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.5.2133 · Cited by 422
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Francone, O. L., Gurakar, A., & Fielding, C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83541-4 · Cited by 280
Rubin, E. M., Ishida, B. Y., Clift, S. M., & Krauss, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.434 · Cited by 274
Walsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 241
Self-citationHarris, H. W., Grunfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116259 · Cited by 214
Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide
Cavaillon, J. M., Fitting, C., Haeffner-Cavaillon, N., Kirsch, S. J., & Warren, H. S. (1990) · Infection and Immunity · doi:10.1128/iai.58.7.2375-2382.1990 · Cited by 185
Van Lenten, B. J., Fogelman, A. M., Haberland, M. E., & Edwards, P. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2704 · Cited by 185
The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.
Ulevitch, R. J., & Johnston, A. R. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109252 · Cited by 152
Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins
Flegel, W. A., Wolpl, A., Männel, D. N., & Northoff, H. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2237-2245.1989 · Cited by 148
Munford, R. S., Andersen, J. M., & Dietschy, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110404 · Cited by 111
Mode of assembly of amphipathic helical segments in model high-density lipoproteins
Brasseur, R., Meutter, J. D., Vanloo, B., Goormaghtigh, E., Ruysschaert, J., & Rosseneu, M. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90023-q · Cited by 105
Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins
Munford, R. S., Hall, C. L., & Dietschy, J. M. (1981) · Infection and Immunity · doi:10.1128/iai.34.3.835-843.1981 · Cited by 100
[36] Synthetic peptide analogs of apolipoproteins
Anantharamaiah, G. M. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28096-9 · Cited by 99
Modulation of Endotoxic Activity of Lipopolysaccharide by High-Density Lipoprotein
Baumberger, C., Ulevitch, R. J., & Dayer, J. M. (2008) · Pathobiology · doi:10.1159/000163681 · Cited by 96
Wollenweber, H. W., & Morrison, D. C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95703-0 · Cited by 92
Weiser, M. M., & Rothfield, L. I. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)56990-3 · Cited by 75
Chajek‐Shaul, T., Hayek, T., Walsh, A., & Breslow, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6731 · Cited by 72
Self-citationTobias, P. S., Mcadam, K. P. W. J., Soldau, K., & Ulevitch, R. J. (1985) · Infection and Immunity · doi:10.1128/iai.50.1.73-76.1985 · Cited by 66
An improved chromogenic substrate endotoxin assay for clinical use.
Harris, R. I., Stone, P. C. W., & Stuart, J. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.10.1145 · Cited by 49
High-density lipoproteins in human health and disease.
Glomset, J. A. (1980) · PubMed · Cited by 48
Vanloo, B., Morrison, J. R., Fidge, N., Lorent, G., Lins, L., Brasseur, R., Ruysschaert, J., Baert, J. H., & Rosseneu, M. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41955-8 · Cited by 34
A rapid method for the synthesis of protein-lipid complexes using adsorption chromatography.
Bonomo, E. A., & Swaney, J. B. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38530-8 · Cited by 31
Victorov, A. V., Medvedeva, N. V., Gladkaia, E. M., Morozkin, A. D., Podrez, E. A., Kosykh, V. A., & Yurkiv, V. A. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90351-9 · Cited by 29
Control of variance in experimental studies of hyperlipidemia using the WHHL rabbit.
Donnelly, T. M., Kelsey, S. F., Levine, D., & Ts, P. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41972-8 · Cited by 27
Self-citation
Cited by
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
“In contrast, transgenic mice overexpressing apoA-I, which have high HDL levels, and LDL receptordeficient mice, which have high LDL levels, are resistant to LPS-induced lethality and severe gram-negative infections (315, 316).”
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 783
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Van Amersfoort, E. S., Van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750
Impact of Obesity and Metabolic Syndrome on Immunity
Andersen, C. J., Murphy, K. E., & Fernandez, M. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.010207 · Cited by 701
Metadata
- Authors
- Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-12-15
- Volume
- 90
- Issue
- 24
- Pages
- 12040-12044
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2020361370
- Cited by
- 485
- References
- 39
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.